[{"title": "BioXcel Therapeutics (BTAI) Stock Is Extremely Volatile Today: What's Going On?", "url": "https://www.benzinga.com/trading-ideas/movers/25/08/47067909/bioxcel-therapeutics-btai-stock-is-extremely-volatile-today-whats-going-on", "snippet": "Shares of BioXcel Therapeutics are trading sharply lower Tuesday morning. The company announced its financial results for Q2.", "published": "2025-08-12T17:02:00+00:00"}, {"title": "3 Supercharged Stocks Flashing Strong Momentum Signals", "url": "https://www.aol.com/3-supercharged-stocks-flashing-strong-183331890.html", "snippet": "Several stocks have shown strong momentum in recent sessions as broader markets charge to all-time highs. Here's a look at some standout momentum movers that are just starting to pick up steam. 3 Momentum Names To Watch Benzinga's rankings system assigns scores to stocks based on momentum,", "published": "2025-08-13T21:33:00+00:00"}, {"title": "BioXcel Therapeutics, Inc. (BTAI) Reports Q2 Loss, Lags Revenue Estimates", "url": "https://www.msn.com/en-us/money/topstocks/bioxcel-therapeutics-inc-btai-reports-q2-loss-lags-revenue-estimates/ar-AA1KoJJS", "snippet": "BioXcel Therapeutics, Inc. (BTAI) came out with a quarterly loss of $2.45 per share versus the Zacks Consensus Estimate of a loss of $2.3. This compares to a loss of $3.36 per share a year ago. These figures are adjusted for non-recurring items.", "published": "2025-08-12T19:00:03+00:00"}, {"title": "BioXcel Highlights BXCL501's Market Potential for Agitation", "url": "https://www.theglobeandmail.com/investing/markets/stocks/BTAI/pressreleases/34074447/bioxcel-highlights-bxcl501s-market-potential-for-agitation/", "snippet": "Detailed price information for Bioxcel Therapeutics Inc (BTAI-Q) from The Globe and Mail including charting and trades.", "published": "2025-08-12T07:12:00+00:00"}]